Abstract
Hepatitis C virus (HCV)-related cirrhosis is a leading indication for liver transplantation (LT) worldwide. Access to effective HCV treatment is inequitable globally. We aimed to analyze whether the introduction of effective HCV treatment caused an impact in LT trends in a middle-income country. Cross-sectional analysis of all adult patients who were listed/received a LT in Argentina for HCV, alcohol-related liver disease (ALD), or autoimmune hepatitis/primary biliary cirrhosis (AIH/PBC) from 2007 to 2017. Joinpoint regression analysis was used to identify changes in the cumulative incidence rates in waiting list (WL) registration, WL mortality, and LT. Liver transplantation WL for HCV increased significantly between 2007 and 2014, with an annual percentage change (APC) +7.8%, P = .01, followed by a downward slope from 2014 to 2017 with an APC -9.8%, P = .1. There were no significant changes in WL mortality. LT trends remained stable. LT for HCV without MELD exception points for HCC decreased (APC -6.6%, P = .01), whereas LT for HCV with HCC exception points increased (APC +11.1, P = .01) during the study period. Waiting list and LT for HCV without HCC decreased, whereas LT for HCV and HCC increased; this may be related to sele...Continue Reading
References
Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Jun 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Timothy R MorganUNKNOWN HALT-C Trial Group
Sep 26, 2012·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Scott W BigginsJohn P Roberts
Dec 27, 2012·JAMA : the Journal of the American Medical Association·Adriaan J van der MeerHarry L A Janssen
Jan 1, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert J WongAijaz Ahmed
Aug 6, 2014·Transplantation·Paolo R SalvalaggioMario Vilatoba
Sep 23, 2014·Digestive Diseases and Sciences·Chansoo MoonKwang-Hyub Han
Jan 8, 2015·European Journal of Gastroenterology & Hepatology·Federico PiñeroMarcelo Silva
Jul 17, 2015·Clinical Pharmacology and Therapeutics·J FlorianV Sinha
Aug 8, 2015·Alimentary Pharmacology & Therapeutics·K DeterdingH Wedemeyer
Feb 2, 2016·Journal of Hepatology·Graham R FosterUNKNOWN HCV Research, UK
Mar 26, 2016·Alcoholism, Clinical and Experimental Research·Isabel LegazManuel Muro
May 24, 2016·Journal of Hepatology·Luca Saverio BelliUNKNOWN European Liver and Intestine Association (ELITA)
Dec 25, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jennifer A FlemmingNorah A Terrault
Jan 5, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·François Durand, Claire Francoz
Jan 16, 2017·Gastroenterology·David GoldbergMichael Charlton
Mar 16, 2017·BMC Medicine·Thomas F BaumertYujin Hoshida
Mar 23, 2017·World Journal of Hepatology·Francesca Romana PonzianiAntonio Gasbarrini